SDZ-216-525

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSDZ-216-525
Drug Alias NameSDZ-216-525
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 1a (5-HT1a) receptor antagonists
TargetsSerotonin 1a (5-HT1a) receptor
Therapy Area/IndicationsAnxiety Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Ag
Active IndicationsN/A
Inactive IndicationsAnxiety Disorders

Other Information

ATC CodeN/A
Related LinksN/A